Cynosure Group LLC decreased its holdings in shares of Huron Consulting Group Inc. (NASDAQ:HURN – Free Report) by 16.4% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 3,287 shares of the business services provider’s stock after selling 645 shares during the period. Cynosure Group LLC’s holdings in Huron Consulting Group were worth $357,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently made changes to their positions in HURN. Assetmark Inc. boosted its holdings in shares of Huron Consulting Group by 7.0% during the third quarter. Assetmark Inc. now owns 1,373 shares of the business services provider’s stock worth $149,000 after purchasing an additional 90 shares during the period. Andina Capital Management LLC boosted its holdings in shares of Huron Consulting Group by 4.5% during the 3rd quarter. Andina Capital Management LLC now owns 3,189 shares of the business services provider’s stock valued at $347,000 after buying an additional 137 shares in the last quarter. Creative Planning increased its stake in shares of Huron Consulting Group by 10.5% in the 3rd quarter. Creative Planning now owns 2,588 shares of the business services provider’s stock worth $281,000 after acquiring an additional 246 shares in the last quarter. Ashton Thomas Private Wealth LLC bought a new stake in Huron Consulting Group during the second quarter worth about $28,000. Finally, Diversified Trust Co grew its holdings in Huron Consulting Group by 7.5% in the second quarter. Diversified Trust Co now owns 5,452 shares of the business services provider’s stock worth $537,000 after purchasing an additional 380 shares during the period. Hedge funds and other institutional investors own 93.90% of the company’s stock.
Huron Consulting Group Stock Down 0.7 %
HURN opened at $123.70 on Friday. Huron Consulting Group Inc. has a twelve month low of $84.26 and a twelve month high of $131.06. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.82. The firm has a 50 day moving average price of $113.62 and a 200-day moving average price of $105.15. The stock has a market capitalization of $2.19 billion, a price-to-earnings ratio of 26.89 and a beta of 0.60.
Insiders Place Their Bets
In other news, Director James H. Roth sold 2,000 shares of the company’s stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $128.42, for a total value of $256,840.00. Following the completion of the sale, the director now directly owns 54,825 shares in the company, valued at $7,040,626.50. This represents a 3.52 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director H Eugene Lockhart sold 1,042 shares of Huron Consulting Group stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $108.27, for a total value of $112,817.34. Following the transaction, the director now owns 28,840 shares in the company, valued at $3,122,506.80. This trade represents a 3.49 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 5,126 shares of company stock valued at $604,420. Insiders own 2.02% of the company’s stock.
Analyst Upgrades and Downgrades
A number of analysts have weighed in on HURN shares. Benchmark restated a “buy” rating and set a $140.00 price objective on shares of Huron Consulting Group in a research note on Wednesday, October 30th. Barrington Research upped their price objective on Huron Consulting Group from $137.00 to $142.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Finally, StockNews.com raised Huron Consulting Group from a “hold” rating to a “buy” rating in a report on Thursday, October 31st. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $133.00.
Get Our Latest Stock Analysis on HURN
About Huron Consulting Group
Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.
Further Reading
- Five stocks we like better than Huron Consulting Group
- Investing in Commodities: What Are They? How to Invest in Them
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Stock Analyst Ratings and Canadian Analyst Ratings
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Why Are Stock Sectors Important to Successful Investing?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding HURN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Huron Consulting Group Inc. (NASDAQ:HURN – Free Report).
Receive News & Ratings for Huron Consulting Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huron Consulting Group and related companies with MarketBeat.com's FREE daily email newsletter.